Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

Ufuk Avrupa (Horizon Europe) · çağrı konusu HORIZON-HLTH-2027-02-TOOL-01-two-stage (Cluster 1 - Health (Two stage - 2027)). Eylem türü: HORIZON Research and Innovation Actions.

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:

• Clinical researchers and developers have access to novel predictive biomarkers to guide a more accurate assessment of disease progression and treatment response and tackle the unmet clinical needs of non-communicable chronic diseases.
• Clinicians and healthcare professionals use clinically validated predictive biomarkers for implementing more effective clinical research and personalised medicine with better health outcomes in chronic non-communicable diseases. …

Kaynak: Avrupa Komisyonu Funding & Tenders Portal (otomatik aktarım; ayrıntı ve güncel koşullar için resmî sayfaya bakın).

"> General conditions

• Admissibility Conditions, proposal page limit and layout

Applicants submitting a proposal for a blind evaluation (see General Annex F) must not disclose their organisation names, acronyms, logos nor names of personnel in the proposal abstract and Part B of their first-stage application (see General Annex E).

Admissibility conditions are  described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes. …

Uygunluk: ülkenizin bu programa katılım durumunu ve ortaklık şartlarını resmî konu sayfasından teyit edin.